Literature DB >> 11020173

Computed tomography stage, allergy testing, and quality of life in patients with sinusitis.

J H Krouse1.   

Abstract

BACKGROUND: Chronic rhinosinusitis is a common disease associated with significant morbidity. CT has been a poor predictor of the extent of symptoms among these patients. Allergic rhinitis is frequently associated with chronic rhinosinusitis. This study examines CT stage, allergic sensitivity, and sinus-related symptoms.
METHODS: Forty-eight patients with chronic rhinosinusitis underwent CT scanning and skin end-point titration (SET). They also completed the Rhinosinusitis Disability Index (RSDI), a measure of sinus-related disability.
RESULTS: No association was noted between CT stage and severity of sinus-related symptoms. There was a significant correlation between CT stage and SET mean end point and between SET mean end point and RSDI physical scale score, as well as between significance on the RSDI emotional scale score and overall score.
CONCLUSION: The degree of allergic disease is a better indicator of symptom severity and impairment in quality of life among patients with chronic rhinosinusitis than CT stage. Careful evaluation and treatment of allergic disease is critical in the treatment of chronic rhinosinusitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020173     DOI: 10.1067/mhn.2000.109476

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  18 in total

1.  The Utility of Radiologic Studies in the Diagnosis and Management of Rhinosinusitis.

Authors:  Andrew H. Marshall; Nick S. Jones
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Sinusitis and its management.

Authors:  Kim W Ah-See; Andrew S Evans
Journal:  BMJ       Date:  2007-02-17

Review 3.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

Review 4.  Perennial rhinitis.

Authors:  Hesham A Saleh; Stephen R Durham
Journal:  BMJ       Date:  2007-09-08

5.  Atopic profile of patients failing medical therapy for chronic rhinosinusitis.

Authors:  Bruce K Tan; Whitney Zirkle; Rakesh K Chandra; David Lin; David B Conley; Anju T Peters; Leslie C Grammer; Robert P Schleimer; Robert C Kern
Journal:  Int Forum Allergy Rhinol       Date:  2011 Mar-Apr       Impact factor: 3.858

Review 6.  [Quality of life. An important parameter in respiratory tract diseases].

Authors:  I Kirchberger
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

7.  Diagnostic strategies in nasal congestion.

Authors:  John Krouse; Valerie Lund; Wytske Fokkens; Eli O Meltzer
Journal:  Int J Gen Med       Date:  2010-04-08

8.  Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy.

Authors:  Aaron N Pearlman; Rakesh K Chandra; Dennis Chang; David B Conley; Anju Tripathi-Peters; Leslie C Grammer; Robert T Schleimer; Robert C Kern
Journal:  Am J Rhinol Allergy       Date:  2009 Mar-Apr       Impact factor: 2.467

9.  Correlation of histopathology and symptoms in allergic and non-allergic patients with chronic rhinosinusitis.

Authors:  Tomislav Baudoin; Livije Kalogjera; Goran Geber; Marko Grgić; Hrvoje Cupić; Mirjana Kujundzić Tiljak
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

10.  Three-dimensional volumetric computed tomographic scoring as an objective outcome measure for chronic rhinosinusitis: clinical correlations and comparison to Lund-Mackay scoring.

Authors:  John F Pallanch; Lifeng Yu; David Delone; Rich Robb; David R Holmes; Jon Camp; Phil Edwards; Cynthia H McCollough; Jens Ponikau; Amy C Dearking; John Lane; Andrew Primak; Aaron Shinkle; John Hagan; Evangelo Frigas; Joseph J Ocel; Nicole Tombers; Rizwan Siwani; Nicholas M Orme; Kurtis B Reed; Nivedita Jerath; Robinder Dhillon; Hirohito Kita
Journal:  Int Forum Allergy Rhinol       Date:  2013-09-17       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.